Beclomethasone
From Anvita Health Wiki
Contents |
Introduction
- Tradenames: Vanceril, Beclovent.
Indications
- treatment of asthma ( inhaler)
- relief of rhinitis (nasal spray)
- prevention of recurrence of nasal polyps following surgical removal
Contraindications
- status asthmaticus
- hypersensitivity to beclomethasone, fluorocarbons or oleic acid in the formula
- pregnancy category = c
- safety in lactation = -
- safety in lactation = ?
Dosage
- inhaler: 2 puffs TID/ QID., 42 ug/ inhalation. 16.8 g
- Qvar: 40 & 80 ug/ inhalation; uses non- ozone-depleting hydrofluorohydrocarbons; smaller particle size; no spacer needed
- nasal spray: inhalation in affected nostril(s) BID- QID 42 ug/ inhalation. 16.8 g.
Pharmacokinetics
-
- some improvement may occur within 1 week
- general 1-4 weeks required for significant improvement
- nasal spray: onset of action
- relief of symptoms generally occurs within a few days, but may take as long as 2 weeks
- relief of symptoms generally occurs within a few days, but may take as long as 2 weeks
- elimination via liver
Adverse-effects
- Vanceril
- systemic absorption is low
- if correct technique is not used, hypothalamic- pituitary- adrenal function
- oral thrush is common especially if patients do not rinse after use
- irritation: cough, hoarseness, xerostomia
- rare (< 1%)
- skin rash, bronchospasm, difficulty swallowing
- Vancenase, Beconase
- irritation of nasal mucosa
- epistaxis
- rare (< 1%)
- headache, rhinorrhea, nasal stuffiness, sneezing, nasal ulceration & septal perforation
- headache, rhinorrhea, nasal stuffiness, sneezing, nasal ulceration & septal perforation
Mechanism-of-action
- nasal preparation
- does NOT inhibit IgE synthesis or mast cell degranulation
- inhibits cytokine production, arachidonate metabolism, inflammation & mast cell proliferation
More General Terms
Internet Database
PubChem: 2307
PubChem: 20469
PubChem: 2308
PubChem: 657383
PubChem: 217100
References
- The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 85
- Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998 - not on National VA formulary
- Kaiser Permanente Northern California Regional Drug Formulary, 1998
- Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
- Prescriber's Letter 7(11):64 2000
